Skip to main content

Advertisement

SpringerLink
Log in

A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

A Correction to this article was published on 03 November 2023

This article has been updated

Abstract

Chronic myelomonocytic leukemia is a myeloid stem cell disease characterized by an abnormal production and accumulation of monocytic cells in association with other signs of myeloproliferation. Extramedullary manifestations of CMML are common and can affect the spleen, liver skin, and lymph nodes. However, otologic manifestations are extremely rare and could have occurred from either direct leukemic infiltration, hemorrhage of the cochlea, labyrinth, leukostasis, or infection. There is no standard treatment protocol for sensorineural hearing loss in CMML patients. More research is needed to improve the understanding of the pathogenesis of this condition, in order to provide better treatment options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

Data used in this manuscript is not publicly available in order to protect patient confidentiality. Reasonable request should be directed to the corresponding author.

Change history

References

  1. Valent P, Orazi A, Savona MR et al (2019) Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions. Haematologica 104(10):1935–1949

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Pudasainee P, Pyakuryal B, Subedi Y et al (2019) Extramedullary manifestation of chronic myelomonocytic leukemia: do we treat an acute myeloid leukemia? Case Rep Hematol 2019:8360454. https://doi.org/10.1155/2019/8360454

    Article  PubMed  PubMed Central  Google Scholar 

  3. Chae SW, Cho JH, Lee JH et al (2002) Sudden hearing loss in chronic myelogenous leukaemia implicating the hyperviscosity syndrome. J Laryngol Otol 116:291–293

    Article  PubMed  Google Scholar 

  4. Cass ND, Gubbels SP, Portnuff CDF (2018) Sudden bilateral hearing loss, tinnitus, and vertigo as presenting symptoms of chronic myeloid leukemia. Ann Otology, Rhinol Laryngol 127(10):731–734

    Article  Google Scholar 

  5. Kim HJ, Park EK, Moon IS (2014) A case of sudden hearing loss during treatment with decitabine for chronic myelomonocytic leukemia. Chinese J Cancer Res 26(1):E1–E4

    Google Scholar 

  6. Kayode AS, Adeleke IA, Oluwatona DA (2018) Sudden sensineural hearing loss in patient with chronic myelogenous leukemia – a case study. Arch Otolaryngol Rhinol 4(4):082–084

    Article  Google Scholar 

  7. Thiel-Klare K, Rogers A, Boston R et al (2022) Mouse model of combination targeted therapy in PTPN11 driven leukemia. Blood 140(Supplement 1):10687–10688. https://doi.org/10.1182/blood-2022-160358

    Article  Google Scholar 

  8. Greipp PT, Hanson CA, Sharma RG et al (2009) Whole arm duplication of 1q in myeloid neoplasm, with Emphasis On Derivative (1;7)(q10;p10). Blood 114(22):4238. https://doi.org/10.1182/blood.V114.22.4238.4238

    Article  Google Scholar 

  9. Schreiber BE, Agrup C, Haskard DO et al (2010) Sudden sensorineural hearing loss. The Lancet 375:1203–1211

    Article  Google Scholar 

  10. Chandrasekhar SS, Tsai Do BS, Schwartz SR et al (2019) Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head & Neck Surg 161(1_suppl):S1–S45. https://doi.org/10.1177/0194599819859885

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Leukemia, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA

    Rodrick Babakhanlou & Yesid Alvarado

  2. Department of Head and Neck Surgery, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA

    Marc-Elie Nader

Authors
  1. Rodrick Babakhanlou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc-Elie Nader
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yesid Alvarado
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RB wrote the manuscript.

MEN corrected and approved the manuscript and provided figures.

YA read and approved manuscript.

Corresponding author

Correspondence to Rodrick Babakhanlou.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from patient to publish data.

Conflict of interest

RB has no conflict of interest.

MEN reports stock ownership in 3M, Amgen, Johnson & Johnson, Medtronic, and Pfizer.

YA has no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original version of this article was revised: This article was originally published with the name of one of the co-authors was inadvertently misspelled. The incorrect spelling "Marc Ellie-Nader" should be corrected to "Marc-Elie Nader."

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Babakhanlou, R., Nader, ME. & Alvarado, Y. A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia. Ann Hematol 102, 3427–3430 (2023). https://doi.org/10.1007/s00277-023-05433-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05433-w

Keywords

Search

Navigation